US recommends ‘pause’ to Johnson & Johnson jab rollout over blood clot fears

US

The US Food and Drug Administration has recommended a “pause” to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.

Officials say they are looking into six reported cases “of a rare & severe type of blood clot in individuals after receiving the vaccine”.

“Right now, these adverse events appear to be extremely rare,” the FDA said in a statement on Twitter.

It said until the cases had been assessed for their potential significance, “we are recommending this pause”.

“This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot,” it added.

Products You May Like

Articles You May Like

I lived through China’s COVID lockdowns for the best part of three years – it’s a miserable existence
Royal Mail staff and university lecturers strike today as industrial unrest continues
Murders of two 16-year-old boys in London linked as victims named
Billie Eilish to headline Prince William’s Earthshot Prize awards
BlockFi lawyer tells bankruptcy court that the priority is to ‘maximize client recoveries’

Leave a Reply

Your email address will not be published. Required fields are marked *